EMPLOYMENT AGREEMENTEmployment Agreement • November 4th, 2021 • Passage BIO, Inc. • Biological products, (no disgnostic substances) • Pennsylvania
Contract Type FiledNovember 4th, 2021 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (this “Agreement”) is entered into effective as of August 23, 2021 by and between Passage BIO, Inc. (the “Company”), and Simona C. King (the “Employee”) (collectively, the “Parties”).
CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [*], HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO PASSAGE BIO, INC. IF PUBLICLY DISCLOSED. FIFTH AMENDMENT TO AMENDED AND RESTATED...License Agreement • November 4th, 2021 • Passage BIO, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledNovember 4th, 2021 Company IndustryThis Fifth Amendment (“Fifth Amendment”) is effective as of August 3, 2021 (“Fifth Amendment Effective Date”) to amend the Amended and Restated Research, Collaboration & License Agreement, as amended to date (the “Agreement”) entered into as of May 5, 2020 by and between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Passage Bio, Inc., a corporation organized under the laws of the state of Delaware (“Licensee”). Penn and Licensee may be referred to herein as a “Party” or, collectively, as “Parties”. Capitalized terms that are used but not defined herein shall have the meanings ascribed to such terms in the Agreement.